The National Institute of Allergy and Infectious Disease Vaccine and Treatment Evaluation Units (NIAID VTEUs) play a key role in the development new and improved vaccines and therapies against infectious diseases. VTEUs have run hundreds of clinical trials, many of which have contributed vaccines becoming licensed for use. A key feature of the VTEUs' success is their ability to enroll large numbers of volunteers into trials rapidly and vaccinate them in a safe, effective and quick manner.
The RBL Immunology Unit is a service component of the Regional Biocontainment Laboratory at Duke (housed in GHRB). In addition to providing access to specialized instrumentation for Real-Time PCR, and Luminex-based multiplex assays, this unit assists investigators with design and implementation of molecular, protein, and cellular assays to quantify immune reconstitution or immune responses in vitro and in vivo.